sur VALBIOTIS (EPA:ALVAL)
Valbiotis signs an exclusive distribution agreement in the Middle East
Valbiotis, a French laboratory specializing in food supplements, announces an exclusive partnership with Mena Nutrition for the distribution of its products in the Middle East. Mena Nutrition, with 20 years of experience, will market Valbiotis products in Saudi Arabia, Lebanon, and Iraq.
This new agreement, following its development in Asia, represents a key milestone for Valbiotis. The products, designed to prevent cardiometabolic imbalances, will benefit from Mena Nutrition's logistical and commercial expertise, without requiring any direct investment from Valbiotis.
Initial revenues are expected by the end of 2026, subject to regulatory approvals. This agreement reinforces Valbiotis' ambitions for international expansion, strengthening its position in high-potential markets. It also demonstrates the company's commitment to responsible and innovative preventive healthcare.
R. E.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de VALBIOTIS